Depacon and cerebrovascular arteriovenous malformation Patient Reports February 12, 2012

Depacon Side Effects Report #4704089-1
Depacon side effect was reported by a Consumer or non-health professional from on June 02, 2005. Female patient, 21 years of age, was diagnosed with convulsion prophylaxis, pyrexia and was treated with Depacon. After drug was administered, patient experienced the following side effects: cerebrovascular arteriovenous malformation, pancytopenia. Depacon dosage: 1500.0 MG (500.0 MG, 3 IN 1 D) INTRAVENOUS. During the same period patient was treated with CLORAZEPATE DIPOTASSIUM, METAMIZOLE MAGNESIUM, OMEPRAZOLE, ACETAMINOPHEN, KETOROLAC TROMETHAMINE, BUPRENORPHINE, ONDANSETRON HYDROCHLORIDE. Patient was hospitalized. Patient recovered.